Atria Wealth Solutions, Inc. Repligen Corp Transaction History

Atria Wealth Solutions, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$170.78 - $208.42 $336,607 - $410,795	1,971 New	1,971 $362,000
Q1 2023 Aug 22, 2023	BUY	$154.26 - $198.1 $489,004 - $627,977	3,170 New	3,170 $533,000
Q1 2023 Jun 14, 2023	BUY	$154.26 - $198.1 $94,098 - $120,841	610 Added 19.24%	3,780 $636,000
Q1 2023 May 10, 2023	SELL	$154.26 - $198.1 $101,657 - $130,547	-659 Reduced 17.21%	3,170 $533,000
Q4 2022 Aug 30, 2023	BUY	$162.42 - $220.56 $613,947 - $833,716	3,780 New	3,780 $639,000
Q4 2022 Feb 13, 2023	SELL	$162.42 - $220.56 $675,667 - $917,529	-4,160 Reduced 52.07%	3,829 $648,000
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $1.28 Million - $2.05 Million	7,989 New	7,989 $1.5 Million
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $1.35 Million - $1.8 Million	-9,564 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $1.54 Million - $2.47 Million	9,564 New	9,564 $1.8 Million

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.